Search Results 371-380 of 20691 for Informed consent

1. Pharmacogenomics (PGx) results and clinical data for assessing current and future therapeutic relevance.

   Patients must understand and provide written informed consent and HIPAA authorization prior to initiation of any study-specific procedures. Patient is ...

2. A Study of King-Devick test (KDT) and Visual Contrast Sensitivity (VCS) Test Can Detect Migraine Attacks - Mayo Clinic

   Inability to provide informed consent; Individuals with the following condition: Presence of medication overuse (using NSAIDs more than 15 days per month, or ...

3. APOL1 Long-term Kidney Transplantation Outcomes Network (APOLLO) - Mayo Clinic

   Participants who are unable or unwilling to provide informed consent. Inclusion Criteria for Recipients: Recipients of a kidney transplant from an eligible ...

4. A Study to Evaluate Zoledronic Acid for Fracture Prevention in Parkinson's Disease Patients - Mayo Clinic

   Willing and able to provide informed consent. Exclusion Criteria: History of hip fracture. Any use of a bisphosphonate drug within the last 12 months. Use ...

5. AI-SCREENDCM Decentralized Clinical Trial - Pilot Study

   Proband has provided informed consent; FDR able to provide informed consent; Access to a smartphone or digital tablet with cellular data or Wi-Fi access.

6. hTERT Immunotherapy Alone or in Combination With IL-12 DNA Followed by Electroporation in Adults With Solid Tumors at High Risk of Relapse - Mayo Clinic

   ... informed consent as described below for each indication: Breast carcinoma: Lung carcinoma: Pancreatic carcinoma: Head and neck squamous cell carcinoma ...

7. Phase 2 Trial of Blinatumomab in Philadelphia Positive/BCR-ABL Positive Acute Lymphoblastic Leukemia - Mayo Clinic

   Subject has provided informed consent or subject's legally acceptable representative has provided informed consent when the subject has any kind of ...

8. A Comparison Study to Cross-validate the Linear Analogue Self-Assessment (LASA), Patient-Reported Outcomes Measurement Information System (PROMIS), and Patient-reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE) in Assessing Cancer Patient Well-being - Mayo Clinic

   Provide written informed consent. Ability to participate in the study visit lasting 45-60 minutes total. Exclusion Criteria. Clinically significant cognitive ...

9. A Study to Assess a Multicenter Cancer Biospecimen Collection - Mayo Clinic

   Willing to provide electronic informed consent per IRB-approved protocol. Able to speak, read, and comprehend English fluently. Subject is 18 years of age ...

10. Tucatinib and Trastuzumab for Patients with HER2-positive Metastatic Colorectal Cancer - Mayo Clinic

    ... informed consent and continuing throughout the study and for at least 7 months after the final dose of any study drug. Subject must provide signed informed ...